Stock Valuation / ISRG
Is Intuitive Surgical, Inc. (ISRG) Overvalued? Fair Value & 5-Year Target
Intuitive Surgical, Inc. trades at $422.06 (P/E 48.46). Our reference model estimates a fair value of $458.74 at its recent average P/E of 52.67.
| Current price | $422.06 |
|---|---|
| Current EPS | $8.71 |
| Current P/E | 48.46 |
| Average P/E | 52.67 |
| Fair value (at avg P/E) | $458.74 |
| Upside to fair value | +8.7% |
| Illustrative 5-yr target (25× P/E, 15% growth) | $437.97 |
What drives ISRG's valuation
Changing either assumption moves the target: a higher P/E multiple or faster EPS growth raises fair value, a lower multiple or slower growth lowers it. The interactive dashboard lets you edit both and re-run the model instantly.
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; in
Frequently asked questions
What is ISRG's fair value?
At its recent average P/E of 52.67, Intuitive Surgical, Inc. (ISRG) has a reference fair value of about $458.74, which is +8.7% versus the current price of $422.06.
Is Intuitive Surgical, Inc. (ISRG) overvalued or undervalued?
Based on the average-P/E reference model, Intuitive Surgical, Inc. looks undervalued relative to fair value by roughly +8.7%. This is a model output, not investment advice — change the P/E and growth assumptions in the dashboard for your own view.
What is a 5-year price target for ISRG?
Under an illustrative model of 25× P/E and 15% annual EPS growth, the implied 5-year target is $437.97. Adjust both inputs on the interactive page to match your assumptions.
Open the interactive ISRG valuation dashboard →
Figures are for informational purposes only and are not investment advice. Data as of 2026-10-14.